The global hydrogel dressing market size is anticipated to reach USD 1.24 billion by 2030 and is anticipated to expand at a CAGR of 4.32% over the forecast period, according to a new report by Grand View Research, Inc. The market growth can be accredited to rising prevalence of chronic wounds globally. The properties of hydrogel-based dressings can be adjusted much more easily compared to conventional chronic wound therapy methods. Moreover, owing to their adaptability and versatility, hydrogel dressings can be loaded with cells, antibacterial, antiviral, and antifungal agents, growth factors, and biomolecules to hasten wound contraction and healing. Furthermore, owing to their ability to create in situ and cytocompatible chemical crosslinking, these dressings may be easily applied to irregular or deep wounds. Thereby, owing to above-mentioned advantages, it is expected to propel the market growth.
Massive research is being conducted to create novel hydrogel products from natural sources such as animal tissues, plant extracts, extracellular matrix, and others. Firms are extensively spending in R&D and are continuously working on achieving positive clinical trial results. For instance, Remedor Biomed Ltd. is conducting clinical studies on a hydrogel containing erythropoietin to treat diabetic foot ulcers. In addition, a variety of peptides are being studied in clinical studies for their wound healing abilities. Thus, rigorous clinical studies to commercialize novel hydrogel dressing products are expected to drive the growth of the market in upcoming years.
The number of burn injuries are rising globally. For instance as per WHO in October 2023, about 180,000 deaths annually are caused by burns globally. Hydrogel dressings offer a potential substitute for cooling burn wounds through the use of running water, especially in situations involving mass casualty disasters, limited access to clean water, hypothermia, or extensive burns. These dressings facilitate the evaporation of accumulated heat in the skin, contributing to more effective healing in burn injuries due to their elevated water content. Therefore, the market is likely to be fueled due to increasing number of burn cases over the forecast period.
Request a free sample copy or view report summary: Hydrogel Dressing Market Report
Based on product, the amorphous segment dominated the market in 2023, owing to extensive use of amorphous hydrogel over impregnated and sheet dressings to treat ulcers and burn wounds
Based on application, the chronic wounds segment dominated the market in 2023 due to growing number of chronic wounds and elderly population
In terms of end-use, the hospitals segment dominated the market in 2023, whereas, the home healthcare segment is projected to witness a fastest CAGR over the forecast period
North America dominated the regional segment with a market share of 45.46% in 2023, due to availability of favorable reimbursement policies and large market players
Grand View Research has segmented the global hydrogel dressing market based on product, application, end-use, and region:
Hydrogel Dressing Product Outlook (Revenue, USD Million, 2018 - 2030)
Amorphous Hydrogel
Impregnated Hydrogel
Sheet Hydrogel
Hydrogel Dressing Application Outlook (Revenue, USD Million, 2018 - 2030)
Acute Wounds
Surgical & Traumatic Wounds
Burns
Chronic Wounds
Diabetic Foot Ulcers
Pressure Ulcers
Venous Leg Ulcers
Other Chronic Wounds
Hydrogel Dressing End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Specialty Clinics
Home Healthcare
Others
Hydrogel Dressing Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Mexico
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List Of Key Players in the Hydrogel Dressing Market
Cardinal Health
Smith & Nephew
3M
Coloplast Corp.
ConvaTec Group PLC
Medline Industries, Inc.
Integra LifeSciences Corp.
McKesson Medical-Surgical
DermaRite Industries, LLC
AMERX Health Care Corp.
"The quality of research they have done for us has been excellent..."